Ex vivo drug sensitivity profiling‐guided treatment of a relapsed pediatric mixed‐phenotype acute leukemia with venetoclax and azacitidine - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Pediatric Blood and Cancer Année : 2022

Ex vivo drug sensitivity profiling‐guided treatment of a relapsed pediatric mixed‐phenotype acute leukemia with venetoclax and azacitidine

Fichier non déposé

Dates et versions

hal-04516957 , version 1 (22-03-2024)

Identifiants

Citer

Fanny Gonzales, Audrey Guilmatre, Adeline Barthélémy, Hélène Lapillonne, Nicolas Pottier, et al.. Ex vivo drug sensitivity profiling‐guided treatment of a relapsed pediatric mixed‐phenotype acute leukemia with venetoclax and azacitidine. Pediatric Blood and Cancer, 2022, 69 (10), ⟨10.1002/pbc.29678⟩. ⟨hal-04516957⟩
8 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More